Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-10-23Clinical Trial Update: Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes [Phase 1]
Phase 1 trial evaluating an explorative co-formulation of insulin degludec with insulin aspart versus separate formulations and versus bipha…
-
CLINICAL_TRIALS trial_result · 2015-10-22Clinical Trial Update: Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 Diabetes [Phase 1]
Phase 1 trial comparing IDegAsp (insulin degludec/insulin aspart) with separate injections of insulin degludec and insulin aspart in adults …
-
CLINICAL_TRIALS trial_result · 2015-10-22Clinical Trial Update: Investigation of Pharmacodynamic Characteristics of Explorative Formulation of Insulin Degludec in Male Subjects With Type 1 Diabetes [Phase 1]
Phase 1 study evaluating pharmacodynamic characteristics of an exploratory insulin degludec formulation in male subjects with Type 1 diabete…
-
CLINICAL_TRIALS research · 2015-10-22Clinical Trial Update: The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating the effect of GLP-1 on postprandial glucagon secretion independent of gastric emptying in individuals wi…
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: Evaluation of the Effect of Pramlintide on Satiety and Food Intake [Phase 2]
Phase 2 trial evaluating the effect of pramlintide on satiety and food intake in adults with Type 1 or Type 2 diabetes. The study status is …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: Crossover Feasibility Study of Portable AP Device With Zone-MPC and HMS and Adapted I:C and Basal Insulin [EARLY_Phase 1]
A completed early-phase crossover feasibility trial evaluating a portable artificial pancreas device with Zone-MPC and HMS for adapting insu…
-
FDA approval · 2015-10-20FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly and Company.
-
CLINICAL_TRIALS research · 2015-10-19Clinical Trial Update: Comparing the Pharmacodynamics and Pharmacokinetics of Explorative Formulation of Insulin Degludec With Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes [Phase 1]
A Phase 1 study update comparing the pharmacodynamics and pharmacokinetics of an explorative insulin degludec formulation with insulin glarg…
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes Mellitus
This clinical trial investigated whether urine plasminogen can predict preeclampsia in pregnant women with type 1 diabetes. The study status…
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Breakfast Nutrition and Inpatient Glycemia [NA]
This update reports on a completed Duke University clinical trial evaluating how breakfast nutrition impacts inpatient glycemic control in p…
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes Mellitus [Phase 2]
A Phase 2 study of Secukinumab in newly diagnosed Type 1 Diabetes Mellitus was terminated, with results subsequently posted.
-
CLINICAL_TRIALS withdrawal · 2015-10-08Clinical Trial Update: A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects With Type 1 Diabetes Mellitus [Phase 1]
Phase 1 pilot trial assessing the safety of Campath-1H (alemtuzumab) in individuals with newly diagnosed Type 1 diabetes mellitus; the study…
-
CLINICAL_TRIALS research · 2015-10-06Clinical Trial Update: Intraportal or Intramuscular Site for Islets in Simultaneous Islet and Kidney Transplantation [NA]
This trial update describes a study evaluating intraportal or intramuscular sites for islet transplantation in patients undergoing simultane…
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: Continuous Glucose Monitoring to Measure Effect of Glycemic Index [NA]
A completed clinical trial evaluated continuous glucose monitoring to measure the effect of glycemic index in individuals with Type 1 diabet…
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Algorithm to Control Postprandial, Post Exercise and Night Glucose Excursions in a Portable Closed Loop Format [NA]
Update on a completed clinical trial evaluating a portable closed-loop insulin delivery algorithm to control postprandial, post-exercise, an…
-
FDA approval · 2015-09-29FDA Approved: TOUJEO — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for TOUJEO (insulin glargine) from Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Comparison of Insulin Degludec With Insulin Glargine in Subjects With Type 1 Diabetes Mellitus [Phase 1]
A Phase 1 clinical trial comparing insulin degludec with insulin glargine in subjects with Type 1 diabetes mellitus to assess safety and pha…
-
FDA approval · 2015-09-25FDA Approved: TRESIBA — Original Application (Novo Nordisk)
FDA approved the original Biologics License Application for Tresiba (insulin degludec) from Novo Nordisk, establishing a long-acting insulin…
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Evaluation of the Bioavailability of Pramlintide [Phase 2]
Phase 2 study evaluating the bioavailability of pramlintide in patients with type 1 or type 2 diabetes has completed. The document reports t…
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control [Phase 3]
A Phase 3 clinical trial update evaluating dose-titration of pramlintide during initiation of therapy to improve glucose control in Type 1 D…
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus [Phase 3]
A Phase 3 long-term safety study of pramlintide in individuals with Type 1 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: An Observational Study to Assess Longitudinal Variation of Immune Biomarkers in Subjects at Risk for Development of Type 1 Diabetes
This clinical trial update reports the completion of an observational study assessing how immune biomarkers vary over time in individuals at…
-
FDA approval · 2015-09-16FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
The FDA approved a supplemental application for AFREZZA (insulin human) from MannKind Corporation.
-
CLINICAL_TRIALS trial_result · 2015-09-16Clinical Trial Update: Model Driven Diabetes Care [NA]
The NCT01774149 'Model Driven Diabetes Care' trial, sponsored by University Hospital of North Norway, in Type 1 diabetes mellitus, has compl…
-
CLINICAL_TRIALS research · 2015-09-11Clinical Trial Update: MoCa Test for the Early Detection of Mild Cognitive Impairment During Annual Assessment of Young Adults With Diabetes and in a Control Group Without Diabetes [NA]
This clinical trial update evaluates the use of the Montreal Cognitive Assessment (MoCA) to detect mild cognitive impairment during annual a…